Clinical Trial Management System Market - Forecasts from 2019 to 2024
The global clinical trial management system (CTMS) market is expected to reach US$1,704.371 million by 2024 from US$948.962 million in 2018 growing at a CAGR of 10.25%. Clinical trial management system (CTMS) is a web based technology solution that centralizes the management aspect of clinical trials resulting in streamline business processes, enhanced efficiency, reduced administrative work and reduced time and cost of clinical trials. Key application area for CTMS include protocol development, data analysis and reporting, collection, monitoring and processing of data, site selection and trial preparation etc. The Clinical Trial Management System (CTMS) market is anticipated to show significant growth during the forecast period rising number of drug development and clinical research activities. Growing trend towards integrating Hospital Information System (HIS) with CTMS will also augment the growth of the market. Rising demand of the CTMS to reduce the cost and administrative burden of the clinical will also boost the adoption of CTMS, thus, having a positive impact on the market. However, issues related to the data security coupled with the high cost of CTMS might hinder the growth of the market during the given time frame.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Clinical Trial Management System (CTMS) market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Clinical Trial Management System (CTMS) market.
Major industry players profiled as part of the report are Oracle, Ennov and Breeze CTMS among others.
Segmentation
By Type
Enterprise CTMS
Site CTMS
By Deployment Model
Cloud Based CTMS
On Premise CTMS
By Component
Services
Software
By End Users
Pharmaceutical and Biopharmaceutical Companies
Other Healthcare Providers
CROs
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Clinical Trial Management System (CTMS) market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Clinical Trial Management System (CTMS) market.
Major industry players profiled as part of the report are Oracle, Ennov and Breeze CTMS among others.
Segmentation
By Type
Enterprise CTMS
Site CTMS
By Deployment Model
Cloud Based CTMS
On Premise CTMS
By Component
Services
Software
By End Users
Pharmaceutical and Biopharmaceutical Companies
Other Healthcare Providers
CROs
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET FORECAST BY TYPE
5.1. Enterprise CTMS
5.2. Site CTMS
6. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET FORECAST BY DEPLOYMENT MODEL
6.1. Cloud Based CTMS
6.2. On Premise CTMS
7. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET FORECAST BY COMPONENT
7.1. Services
7.2. Software
8. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET FORECAST BY END USER
8.1. Pharmaceutical and Biopharmaceutical Companies
8.2. Other Healthcare Providers
8.3. CROs
9. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET FORECAST BY GEOGRAPHY
9.1. North America
9.1.1. The U.S
9.1.2. Canada
9.1.3. Mexico
9.1.4. Others
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. U.K.
9.3.2. France
9.3.3. Germany
9.3.4. Italy
9.3.5. Others
9.4. Middle East and Africa
9.4.1. Saudi Arabia
9.4.2. UAE
9.4.3. Israel
9.4.4. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. India
9.5.3. Australia
9.5.4. South Korea
9.5.5. Others
10. COMPETITIVE INTELLIGENCE
10.1. Competition and Offerings Analysis of Key Vendors
10.2. Strategies of Key Players
10.3. Recent Investments and Deals
11. COMPANY PROFILES
11.1. ArisGlobal LLC
11.2. PAREXEL International Corporation
11.3. RealTime
11.4. Breeze CTMS
11.5. Veeva Systems
11.6. Oracle
11.7. Techsol Corporation
11.8. Business Systems Integration AG
11.9. Ennov
11.10. CBS Limited
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET FORECAST BY TYPE
5.1. Enterprise CTMS
5.2. Site CTMS
6. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET FORECAST BY DEPLOYMENT MODEL
6.1. Cloud Based CTMS
6.2. On Premise CTMS
7. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET FORECAST BY COMPONENT
7.1. Services
7.2. Software
8. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET FORECAST BY END USER
8.1. Pharmaceutical and Biopharmaceutical Companies
8.2. Other Healthcare Providers
8.3. CROs
9. GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) MARKET FORECAST BY GEOGRAPHY
9.1. North America
9.1.1. The U.S
9.1.2. Canada
9.1.3. Mexico
9.1.4. Others
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. U.K.
9.3.2. France
9.3.3. Germany
9.3.4. Italy
9.3.5. Others
9.4. Middle East and Africa
9.4.1. Saudi Arabia
9.4.2. UAE
9.4.3. Israel
9.4.4. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. India
9.5.3. Australia
9.5.4. South Korea
9.5.5. Others
10. COMPETITIVE INTELLIGENCE
10.1. Competition and Offerings Analysis of Key Vendors
10.2. Strategies of Key Players
10.3. Recent Investments and Deals
11. COMPANY PROFILES
11.1. ArisGlobal LLC
11.2. PAREXEL International Corporation
11.3. RealTime
11.4. Breeze CTMS
11.5. Veeva Systems
11.6. Oracle
11.7. Techsol Corporation
11.8. Business Systems Integration AG
11.9. Ennov
11.10. CBS Limited
